Long-Term Treatment with the Calcitonin Gene-Related Peptide Receptor Antagonist Erenumab in CADASIL: Two Case Reports

Long-Term Treatment with the Calcitonin Gene-Related Peptide Receptor Antagonist Erenumab in CADASIL: Two Case Reports

Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) is the most common monogenic form of cerebral small vessel disease, caused by a mutation in the <i>NOTCH3</i> gene on chromosome 19. The main clinical features include migraine (often wit...

Full description

Bibliographic Details
Main Authors: Maria Albanese, Francesca Pescini, Chiara Di Bonaventura, Luigi Francesco Iannone, Silvia Bianchi, Anna Poggesi, Mario Bengala, Nicola Biagio Mercuri, Francesco De Cesaris
Format: Article
Language:English
Published: MDPI AG 2024-03-01
Series:Journal of Clinical Medicine
Subjects:
erenumab
CADASIL
migraine
<i>NOTCH3</i>
CGRP
Online Access:https://www.mdpi.com/2077-0383/13/7/1870

Internet

https://www.mdpi.com/2077-0383/13/7/1870

Similar Items